ribavirin has been researched along with Granulocytic Leukemia, Chronic in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 8 (66.67) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 1 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, Y; Len, Y; Naren, D; Shi, F; Shi, R; Yan, T; Yang, X | 1 |
Kast, RE | 1 |
Atkinson, HD; Bogdanovic, A; Colovic, M; Jankovic, G; Milenkovic, P; Sefer, D; Suvajdzic, N | 1 |
Hata, Y; Natsumeda, Y; Weber, G | 1 |
Gharehbaghi, K; Jayaram, HN; Jayaram, NH; Krohn, K; Paull, KD; Rieser, J | 1 |
Chiba, P; Felzmann, T; Fritzer, M; Pillwein, K; Szekeres, T | 1 |
Engeler, GP; Hoffman, R; Jayaram, HN; Kneebone, P; Lapis, E; Paulik, E; Tricot, G; Weber, G; Zhen, W | 1 |
Cooney, DA; Goldstein, BM; Jayaram, HN; Marquez, VE; Weber, G; Zhen, W | 1 |
Weber, G | 1 |
Eble, JN; Hoffman, R; Jayaram, HN; Nagai, M; Natsumeda, Y; Paulik, E; Tricot, G; Weber, G; Zhen, WN | 1 |
Bhandal, AK; Carter, DL; Moore, DC; Studzinski, GP | 1 |
Hoffman, R; Jayaram, HN; Natsumeda, Y; Tricot, GJ; Weber, G; Yamada, Y; Yamaji, Y | 1 |
1 review(s) available for ribavirin and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinoma, Renal Cell; Drug Screening Assays, Antitumor; Hepacivirus; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Models, Biological; Multiple Myeloma; Ribavirin; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin | 2008 |
1 trial(s) available for ribavirin and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Blast Crisis; Blotting, Northern; Down-Regulation; Gene Expression Regulation; Genes, ras; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Pilot Projects; Ribavirin; RNA; Uric Acid | 1991 |
10 other study(ies) available for ribavirin and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Eukaryotic Initiation Factor-4E; Gene Expression Regulation, Neoplastic; Humans; Imatinib Mesylate; Intracellular Signaling Peptides and Proteins; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Signaling System; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Serine-Threonine Kinases; Ribavirin; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Blast Crisis; Blood Cells; Bone Marrow Cells; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Hematopoietic Stem Cells; Humans; Inhibitory Concentration 50; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Neoplastic Stem Cells; Ribavirin; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2003 |
Tiazofurin decreases Ras-GTP complex in K562 cells.
Topics: Antimetabolites, Antineoplastic; Cell Differentiation; Guanosine; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oncogene Protein p21(ras); Protein Binding; Ribavirin; Tumor Cells, Cultured | 1993 |
Cytotoxicity of a new IMP dehydrogenase inhibitor, benzamide riboside, to human myelogenous leukemia K562 cells.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Molecular Structure; Nucleosides; Ribavirin; Ribonucleotides | 1992 |
Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin.
Topics: Antimetabolites, Antineoplastic; Cell Cycle; Guanosine Triphosphate; Humans; IMP Dehydrogenase; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Ribavirin; Tumor Cells, Cultured | 1992 |
Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blast Crisis; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ribavirin | 1992 |
Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Arabinonucleosides; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; IMP Dehydrogenase; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleosides; Ribavirin | 1991 |
IMP dehydrogenase and GTP as targets in human leukemia treatment.
Topics: Adult; Aged; Allopurinol; Antineoplastic Agents; Female; Genes, myc; Genes, ras; Guanosine Triphosphate; Humans; IMP Dehydrogenase; In Vitro Techniques; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Ribavirin; Tumor Cells, Cultured | 1991 |
Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells.
Topics: Animals; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Humans; Kinetics; Leukemia, Experimental; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Receptors, Calcitriol; Receptors, Steroid; Ribavirin; RNA, Messenger; Time Factors | 1991 |
IMP dehydrogenase: inhibition by the anti-leukemic drug, tiazofurin.
Topics: Adenine Nucleotides; Antineoplastic Agents; Blast Crisis; Female; Humans; IMP Dehydrogenase; Ketone Oxidoreductases; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; NADP; Ribavirin; Ribonucleosides | 1989 |